基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the full record of transactions filed by Boyce Sarah, 董事. Insider active across 5 companies, notably Berkeley Lights, Inc.. In total, 38 disclosures have been logged. Breakdown: 1 buy · 7 sells. Total volume traded: €3m. Activity tracked since 14 May 2021. The latest transaction was filed on 21 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
38 条申报中的 25 条
Boyce Sarah is Administrateur. She has filed 38 disclosures in total. Across the 38 sampled filings, the recent activity spans 2016-01-04 to 2026-02-27, with EUR 57,135 of buys and EUR 2,991,339 of sells, and the most frequent transaction type is Levée d'options. Her listed companies are Avidity Biosciences, Inc., where she is President and CEO, OmniAb, Inc., where she is Director, Ligand Pharmaceuticals INC, Ionis Pharmaceuticals INC, where she is Chief Business Officer, and Berkeley Lights, Inc., where she is Director.